Koyfin Home > Directory > Health Care > Amag Pharmaceuticals > Issuance of Common Stock

Amag Pharmaceuticals Issuance of Common Stock Chart (AMAG)

Amag Pharmaceuticals annual/quarterly Issuance of Common Stock from 2010 to 2020.
  • Amag Pharmaceuticals Issuance of Common Stock for the quarter ending June 06, 2020 was $1m a -34.39% decrease of 0m year over year
  • Amag Pharmaceuticals Issuance of Common Stock for the last 12 months ending June 06, 2020 was $1m a -65.40% decrease of -1m year over year
  • Amag Pharmaceuticals Annual Issuance of Common Stock for 2019 was $2m a -152.67% decrease of -2m from 2018
  • Amag Pharmaceuticals Annual Issuance of Common Stock for 2018 was $4m a 22.16% increase of 1m from 2017
  • Amag Pharmaceuticals Annual Issuance of Common Stock for 2017 was $3m a -28.60% decrease of -1m from 2016
Other Cash Flow Metrics:
  • Amag Pharmaceuticals Cash Flow from Operations for the quarter ending December 12, 2018 was $-34m a 162.36% decrease of -55m year over year
  • Amag Pharmaceuticals Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-31m a 66.13% decrease of -21m year over year
  • Amag Pharmaceuticals Total Revenue for the quarter ending September 09, 2018 was $122m a -29.53% decrease of -36m year over year
View Chart On Koyfin

Quarterly AMAG Issuance of Common Stock Data

06/2020$1m
12/2019$1m
09/2019$0m
06/2019$1m
03/2019$0m
12/2018$1m
09/2018$1m
03/2018$0m
12/2017$1m
09/2017$1m

Annual AMAG Issuance of Common Stock Data

2019$2m
2018$4m
2017$3m
2016$4m
2015$423m
2014$8m
2013$1m
2012$0m
2011$1m
2010$168m